Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
Jpn J Clin Oncol
; 52(7): 725-734, 2022 07 08.
Article
de En
| MEDLINE
| ID: mdl-35470391
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs du rectum
/
Tumeurs colorectales
/
Tumeurs du côlon
Type d'étude:
Etiology_studies
/
Prognostic_studies
Limites:
Aged
/
Aged80
/
Humans
Langue:
En
Journal:
Jpn J Clin Oncol
Année:
2022
Type de document:
Article
Pays d'affiliation:
Japon
Pays de publication:
Royaume-Uni